Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Qualman

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The American Journal of Surgical Pathology|May 29, 2007
Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology GroupDavid M Parham, Stephen J Qualman, Lisa Teot, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|January 5, 2005
Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology GroupMelissa C Chiles, David M Parham, Stephen J Qualman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IVAlberto S Pappo, Jane L Meza, Sarah S Donaldson, et al.
Genes, Chromosomes & Cancer|January 25, 2002
Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypesJulia A Bridge, Jian Liu, Stephen J Qualman, et al.
Pediatric Blood & Cancer|May 6, 2004
Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997R Beverly Raney, Julie A Stoner, David O Walterhouse, et al.
Cancer Research|August 17, 2002
Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusionsFrederic G Barr, Stephen J Qualman, Michele H Macris, et al.
BMC Cancer|June 30, 2007
Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cellsChun-Liang Chen, Abbey Loy, Ling Cen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology groupSheri L Spunt, Lynette M Smith, Frederick B Ruymann, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 12, 2006
Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcomaJun Nishio, Pamela A Althof, Jacqueline M Bailey, et al.
Cancer Cell|November 4, 2008
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcomaHuating Wang, Ramiro Garzon, Hao Sun, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The American Journal of Surgical Pathology|May 29, 2007
Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology GroupDavid M Parham, Stephen J Qualman, Lisa Teot, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|January 5, 2005
Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology GroupMelissa C Chiles, David M Parham, Stephen J Qualman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IVAlberto S Pappo, Jane L Meza, Sarah S Donaldson, et al.
Genes, Chromosomes & Cancer|January 25, 2002
Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypesJulia A Bridge, Jian Liu, Stephen J Qualman, et al.
Pediatric Blood & Cancer|May 6, 2004
Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997R Beverly Raney, Julie A Stoner, David O Walterhouse, et al.
Cancer Research|August 17, 2002
Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusionsFrederic G Barr, Stephen J Qualman, Michele H Macris, et al.
BMC Cancer|June 30, 2007
Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cellsChun-Liang Chen, Abbey Loy, Ling Cen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology groupSheri L Spunt, Lynette M Smith, Frederick B Ruymann, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 12, 2006
Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcomaJun Nishio, Pamela A Althof, Jacqueline M Bailey, et al.
Cancer Cell|November 4, 2008
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcomaHuating Wang, Ramiro Garzon, Hao Sun, et al.
Pageof 4